1. Home
  2. ARTL vs GVH Comparison

ARTL vs GVH Comparison

Compare ARTL & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • GVH
  • Stock Information
  • Founded
  • ARTL 2011
  • GVH 2016
  • Country
  • ARTL United States
  • GVH Australia
  • Employees
  • ARTL N/A
  • GVH N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • GVH
  • Sector
  • ARTL Health Care
  • GVH
  • Exchange
  • ARTL Nasdaq
  • GVH Nasdaq
  • Market Cap
  • ARTL 6.7M
  • GVH 7.3M
  • IPO Year
  • ARTL N/A
  • GVH 2023
  • Fundamental
  • Price
  • ARTL $1.80
  • GVH $4.37
  • Analyst Decision
  • ARTL Buy
  • GVH Strong Buy
  • Analyst Count
  • ARTL 2
  • GVH 1
  • Target Price
  • ARTL $30.00
  • GVH $80.00
  • AVG Volume (30 Days)
  • ARTL 535.2K
  • GVH 33.8K
  • Earning Date
  • ARTL 11-12-2025
  • GVH 09-09-2025
  • Dividend Yield
  • ARTL N/A
  • GVH N/A
  • EPS Growth
  • ARTL N/A
  • GVH N/A
  • EPS
  • ARTL N/A
  • GVH 11.95
  • Revenue
  • ARTL N/A
  • GVH $21,878,867.00
  • Revenue This Year
  • ARTL N/A
  • GVH $110,424.81
  • Revenue Next Year
  • ARTL N/A
  • GVH $21.55
  • P/E Ratio
  • ARTL N/A
  • GVH $0.38
  • Revenue Growth
  • ARTL N/A
  • GVH 24.52
  • 52 Week Low
  • ARTL $1.66
  • GVH $3.86
  • 52 Week High
  • ARTL $28.60
  • GVH $364.00
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 23.01
  • GVH 36.58
  • Support Level
  • ARTL $1.72
  • GVH $4.25
  • Resistance Level
  • ARTL $2.24
  • GVH $4.66
  • Average True Range (ATR)
  • ARTL 0.30
  • GVH 0.28
  • MACD
  • ARTL -0.03
  • GVH -0.13
  • Stochastic Oscillator
  • ARTL 4.10
  • GVH 11.54

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

Share on Social Networks: